Objective. To cross-culturally adapt the LupusQoL into French, to test its measurement properties and to further investigate its domain structure.
Introduction life (HRQOL) of SLE patients has been assessed with generic questionnaires, such as the Medical Outcome Study Short-Form 36-item Health Survey (SF-36). Data from these studies have shown that even with inactive disease, SLE patients had a poorer HRQOL compared with healthy subjects [8] . Furthermore, most HRQOL domain scores did not correlate with disease activity and damage assessed by physicians [8] , which shows that HRQOL questionnaires provide different and complementary information. One limitation of previous studies was that some important issues for SLE patients (such as sleep, sexual function and body image) were absent from the generic measures used in SLE [9] . Recently, lupus-specific HRQOL questionnaires have been developed to describe the specific impact of SLE on patients' everyday life, of which two were available at the start of this study [1012] . Of these, LupusQoL was developed in the UK, in patients that are culturally close to French patients, although there are substantial differences between health care systems and ethno-cultural mixes in the two countries. It showed good psychometric properties in English-speaking SLE patients in both the UK [11, 13] and the USA [14, 15] . To date, no lupus-specific HRQOL questionnaire has been validated in French. Our objectives were to cross-culturally adapt the LupusQoL into French, to test its measurement properties and to further investigate its domain structure.
Patients and methods

Study design
We conducted a multicentre prospective cohort study in seven French university hospitals. We included consecutive SLE patients between March and November 2009. The inclusion criteria were age between 18 and 75 years, diagnosis of SLE according to the 1997 modified ACR criteria [16] and the ability to understand and complete self-report questionnaires. Follow-up comprised two visits with the patient's usual SLE specialist (mostly internists) at baseline and 6 months later and two mail surveys 15 days and 3 months after the baseline visit. The study was approved by the Research Ethics Committee (Comité de Protection des Personnes EST 1), and all of the participants gave informed consent.
Data collection
Self-report questionnaires, including the LupusQoL-FR, the Systemic Lupus Activity Questionnaire (SLAQ), the SF-36 and a self-administered visual analogue scale (VAS) from 0 to 100 about SLE activity were collected during each of four assessments. The Safety of Estrogens in Lupus Erythematosus National AssessmentLupus Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) and a Physician Global Assessment on a 0-to 3-point VAS where 3 represents the most severe were scored by investigators at day 0. Investigators were trained to complete the SELENA-SLEDAI. The first author, who had received certified training in SELENA-SLEDAI (H.D.) reviewed all medical records and checked the SELENA-SLEDAI. The ethnicity of the patients was anonymously obtained by asking each investigator to rate the proportion of each ethnic group among patients they included in the study.
The LupusQoL is a lupus-specific HRQOL questionnaire consisting of 34 items grouped in eight domains: physical health, pain, planning, intimate relationships, burden to others, emotional health, body image and fatigue. A score from 0 to 100 (best HRQOL) is calculated for each domain (the method of scoring is presented in the supplementary data, available at Rheumatology online). The SLAQ is a validated patient self-assessed activity questionnaire with a score ranging from 0 to 48 (greatest activity). It includes 24 questions related to disease symptoms assessed by the Systemic Lupus Activity Measure that are amenable to self-report [17, 18] . The SF-36 is a 36-item generic QOL questionnaire consisting of eight domain scores ranging from 0 to 100 (best HRQOL) [19] . The SELENA-SLEDAI instrument is a score that aims to rate SLE activity from 0 to 105 [20] .
Cross-cultural adaptation process
The cross-cultural adaptation was conducted according to published international guidelines [21, 22] . The developer gave her permission to use and translate the instrument and provided a preliminary French translation. Two persons (a rheumatologist and one French-mothertongue English teacher) independently translated the LupusQoL into French. An agreed-on version was written based on the consensus of the two translators and was back-translated into English by a bilingual native English speaker, blinded to the original English version. Then, a multidisciplinary consensus committee comprising the two translators, an internist, two epidemiologists, including one specialized in cross-cultural adaptation met in order to carry out a review of all the available material (original version, preliminary translation, two independent and agreed-on translations and one back-translation) and to conduct the harmonization step. During this meeting, the committee checked that the translation was perfectly understandable, verified cross-cultural semantic, idiopathic and conceptual equivalence of the source and target languages, and produced a pre-final version by consensus. This version was pre-tested in 10 SLE French outpatients. Then, cognitive debriefing in a collective meeting assessed whether they fully understood all items or had problems with the formulation of the French items version. The results of the cognitive debriefing helped modify the pre-final version and produce the final version of the LupusQoL-FR, which was approved by the developer.
Validation study
We used recent international consensus-based definitions of measurement properties [23] . We used SAS software (version 9. 
Validity
Content validity
Patients and SLE experts of the multidisciplinary consensus committee were asked whether all of the items adequately referred to relevant aspects of the construct to be measured, comprehensively reflected the construct and were a representative sample of the total domain for the study population in which the measurement properties were evaluated. Next, we asked the pre-test sample of patients whether the items were understandable for the study population. They were individually asked to reformulate the items of the questionnaire. Patient's reformulation of the items and free comments on the LupusQoL-FR were reviewed by the experts to ensure that item content was correctly captured and for any residual difficulty.
Construct validity
Structural validity. First, we conducted an exploratory factor analysis (EFA) [principal factor analysis (PFA) followed by oblique promax rotation]. We next studied item loading on each factor after rotation, considering 0.5 as significant loading. We computed an eight-factor item loading matrix, according to the a priori hypothesis of an eight-factor structure supported by the original LupusQoL dimensionality. Kaiser's criterion (eigenvalues > 1) [24] , Horn's parallel analysis [25] and graphical analysis of the screeplot [26] were also used to generate hypotheses about the number of factors to be extracted.
Finally we performed a CFA using the UK structure of the LupusQoL. In this analysis, each item was defined to represent only one domain, but the domains were allowed to correlate with each other. Since item responses were not normally distributed, unweighted least-squares estimation was used. As stated in CFA reporting recommendations [27] , we reported (1) the ratio of 2 Rasch analysis. Analyses were conducted separately for each LupusQoL domain. We used a Rasch-derived model for polytomous items in which the distance between response categories was constrained to be equal: the rating scale model [29] . In the Rasch analysis, persons' abilities (quality of life) and difficulties of items are calculated on the same linear scale expressed in log-odds units (logits) [3032] . Detailed methods for IRT analysis are available in supplementary data, available at Rheumatology online. Item fit was assessed using the infit and outfit statistics for each item. Acceptable ranges were set according to Smith's recommendations [33] , considering a sample size of 182 patients, at 0.851.15 and 0.561.44 for infit and outfit, respectively. Principal component analysis (PCA) of the residual [34] and residual correlation matrix were examined to ensure unidimensionality and local independence of items.
External validity. Convergent validity was determined by comparing the results of the LupusQoL-FR with those of the SF-36, SLAQ and patient VAS using Spearman's rank correlation. Correlation coefficients >0.50, 0.350.50 and <0.35 were considered strong, moderate and weak, respectively. We hypothesized that the SLAQ score and patient VAS would correlate strongly with the LupusQoL-FR domains. In particular, we expected better correlations with domains related to physical activities than other domains. Common person equating was performed by plotting the person's ability estimated by the Rasch model from the LupusQoL-FR and the corresponding SF-36 scale against each other. SF-36 Rasch estimates were adjusted for the mean difference between SF-36 and LupusQoL. The linear regression line should have a slope close to 1 and an intercept close to 0 to demonstrate that the scales are measuring close concepts [35] . Next, we compared LupusQoL-FR domain scores between groups expected to have different HRQOL using MannWhitney non-parametric tests (divergent validity). We hypothesized that LupusQoL-FR domains would be significantly altered in patients with active disease with a SELENA-SLEDAI score cutoff of 4.
Reliability
Internal consistency
Cronbach's a coefficient computed for each dimension of the LupusQoL-FR was considered satisfactory when 5 0.7.
Testretest reliability was assessed by computing intra-class coefficients, comparing LupusQoL-FR domains scores at baseline and 15 days later in patients whose self-assessed quality of life on a seven-item Likert scale was rated as no change.
Results
Among the 182 patients who agreed to participate, complete data for all study visits were available for 162 patients. We included 160 women, most of whom had inactive disease [SELENA-SLEDAI mean (S.D.) 2.6 (3.5), range 018] ( Table 1 ). The patients were European (Caucasian) (74%), Afro-Caribbean (9%), North African (13%) and Asian (3%).
Cross-cultural adaptation process
Cultural adaptation in the translation process concerned the wording of heading items: for grammatical reasons, the French translation of 'How often' (A quelle fré quence) was omitted from the items and reflected in the answer choices. The translation of answer choices resulted in choosing 'assez souvent' instead of 'une bonne partie du temps' to represent 'a good bit of the time', because the literal translation was considered to be too close to adjacent response choices. The word lethargic (item 32), for which the literal translation, lethargique, would not be understood by many patients, was replaced by 'ralenti' (slowed). 'I am unable to' was initially translated to 'je suis incapable de', which was considered too negative by the pre-test patients. It was replaced by 'je n'arrive pas à ' (I don't manage) or 'je ne peux pas' (I can't) in items 13 and 31.
Validity
Content validity
Both experts from the translation committee and patients agreed that items comprehensively referred to relevant aspects of SLE patients' quality of life. Reformulation of the 34 items by the pre-test sample of patients showed no major distortion of the item's meaning. The mail response rate exceeded 90% at day 15 and 3 months. Patients' feedback was positive both in the pre-test group of patients and in written comments from the mail survey.
Seventeen patients (9.3%) did not respond to at least one LupusQoL-FR item at the baseline visit. Descriptive statistics for LupusQoL-FR are presented in Table 2 . At least one dimension could not be scored because of missing responses for three patients (1.7%). No significant floor effect was observed, but ceiling effects occurred ranging from 10.3% to 52.3%.
Construct validity
Structural validity. PFA resulted in eight first components explaining 96% of the total variance (four with an eigenvalue > 1). Furthermore, parallel analysis led to the retention of an eight-factor structure. Interestingly, screeplot analysis suggested a two-factor structure, accounting for 76% of the total variance.
Rotation with eight factors resulted in items aggregating in a very similar way to the original LupusQoL as shown on the rotated factor pattern (Table 3) . Physical health no. 8 correlated with pain factor (loading 0.78 vs 0.02), planning no. 2 had a higher correlation with physical health (loading 0.42 vs 0.34), fatigue no. 1 had a higher correlation with emotional health (loading 0.30 vs 0.20), and burden to others no. 3 had a higher correlation with emotional health factor (loading 0.46 vs 0.35). The three remaining problematic items had a loading >0.3 but <0.5 with their own factor: physical health no. 7 (loading 0.45), pain no. 1 (loading 0.47) and pain no. 3 (loading 0.3).
The Rasch fit statistics are shown in Table 3 . Three items underfitted according to both outfit and infit statistics: physical health no. 8 (item 8), burden to others no. 3 (item 19) and fatigue no. 1 (item 31). These items were also found to be problematic with factor analysis. Category probability curves showed that the answer choices were correctly ordered for all domains. PFA of residuals showed no major violation of the unidimensionality assumption. No significant local dependencies were found by the computed residual correlation matrix. CFA showed an acceptable fit to the UK-LupusQoL structure (chisq/df = 2.85, CFI = 1.00, SRMR = 0.053). Standardized coefficients for all items in their domains were >0.7. Applying various modification suggested by the EFA did not significantly improve the fit indices. Rotation with two factors resulted in a first factor (aggregated physical) comprising items from physical health, pain, planning and fatigue dimensions. The second factor (aggregated mental) comprised intimate relationship, burden to others, emotional health and body image. Seven of 34 items had a loading <0.5 with both factors, but the loadings were stronger with the factor containing the item's original dimension (Table 4) . Item Rasch fit statistics of each of the two aggregated domains were acceptable, with three items underfitting with both statistics (physical health no. 3, body image no. 4 and fatigue no. 3). The physical aggregated dimension was found to be unidimensional. The PCA residualbased unidimensionality test was significant for the mental aggregated domain (9.34% of t-tests comparing highest positive loaded items vs highest negative loaded items were significant, with 95% CI 5.1, 11.6 excluding 5%). Significant local dependencies were found by computed residual correlation matrix between seven and five pairs of items in the physical and mental aggregated domains, respectively.
External validity
Convergent validity. The LupusQoL-FR correlated strongly with the corresponding SF-36 domains (Table 5) . As expected, Spearman's correlation with the SLAQ was high for domains of the aggregated physical factor (r = 0.69, 0.77, 0.60, 0.75 and 0.69 for physical health, pain, planning, fatigue and aggregated physical, respectively). Domains of the mental aggregated factor also correlated significantly but less strongly with the SLAQ (r = 0.43, 0.50, 0.62, 0.5 and 0.65 for intimate relationship, emotional health, burden to others, body image and aggregated mental, respectively). Similarly, patient VAS of disease activity correlated more closely with physical domains (r = À0.62, À0.65, À0.56 and À0.65 for physical health, pain, fatigue and aggregated physical, respectively). Common person equating using patients' ability Rasch estimates demonstrated that SF-36 and LupusQoL-FR physical domains measured a close concept, with a slope of the regression line of 0.91 (95% CI 0.80, 1.03) and intercept 0.27 (95% CI À0.14, 0.70). This was not the case for pain/bodily pain, fatigue/vitality and emotional health/mental health. Divergent validity. As expected, LupusQoL-FR domains correlated weakly with the Physician Global Assessment (Spearman r = À0.18 to À0.37). LupusQoL-FR was significantly lower for physical health, pain, intimate relationship and aggregated physical domains in active patients (SELENA-SLEDAI 5 4, mean difference range for these domains 7.28.1, Table 6 ).
Reliability
Cronbach's a ranged from 0.85 (fatigue scale) to 0.92 (emotional health scale), which indicates good internal consistency. Aggregated physical and mental domains had higher a (0.95 and 0.94, respectively). Testretest reliability was also good to excellent among 
Discussion
This study provides evidence that the LupusQoL-FR is a valid tool to assess the quality of life of SLE patients. Moreover, we showed that a two-factor structure could be an interesting and complementary way to aggregate LupusQoL-FR domains. This alternative item grouping is conceptually different from the mental component summary (MCS) and physical component summary (PCS) from SF-36 items described by Ware et al. [36] because it was based on the items themselves rather than a higherorder factor analysis on the dimensions. When we sought an optimal number of factors to be extracted, we did not formulate an a priori hypothesis of a two-factor structure.
This structure was suggested by statistical arguments and was consistent with the combination of some of the previously described eight LupusQoL dimensions and with the content of the item. Structural validity was acceptable insofar as the factor structure resulting from the EFA with eight imposed factors was very close to the structure of the original LupusQoL. Indeed, McElhone et al. [11] have already reported high loading for item 8 (physical health no. 8) in pain (0.51 vs 0.50 in the physical health component) and for item 31 (fatigue no. 1) in emotional health (0.31 vs 0.37 in the fatigue component). These two findings were also confirmed in the paper by Jolly et al. [14] about the US version of the LupusQoL. Therefore these problems are probably intrinsic to the LupusQoL rather than being due to the cultural adaptation and should be addressed in a future international study, especially as items 8 and 31 were found to exhibit a poor fit in the Rasch model. Item 8 (physical health) refers to sleep pattern, while item 10 (pain dimension) refers to the extent that the quality of sleep is affected by pain. It is therefore not surprising that the two items were loaded together, which could in part explain the overlap of the physical health and pain dimension in the French, US and UK samples. Item 11 (pain limits my mobility) refers to both physical capacity and pain and was also highly loaded in physical health in the UK sample (0.46 vs 0.49 in the pain dimension), which could explain its poor loading in the French version. Items 13 and 19 had a loading <0.50 in their respective dimension (planning and burden to others) and higher loading in another dimension (physical health for item 13 and emotional health for item 19) , suggesting that these items could have dual concepts referred to in the same item in the French version. An acceptable Rasch fit was found for both the eight domain and two aggregated domain structures. Testretest reliability, internal consistency and convergent/divergent validity were also satisfactory and similar to previous LupusQoL studies considering that validation against a known body image tool was not available in either the US or French version.
Quality of life in our sample was much better than in the US sample, maybe because the two samples differ in terms of ethnicity, health care systems and disease activity patterns. Interestingly, the pattern of domain scores was nearly the same in the two cohorts (the . In other domains the mean difference was close to 10 on the 0100 scale. A study of item differential functioning in an international study could further clarify this issue. As a first limitation, our study recruited mostly outpatients with inactive disease. This could therefore limit the generalization of our results to active SLE patients. Nonetheless, during the 8-month period between March and November 2009, 15% of patients had a moderate/ severe SLE flare, which corresponds to the proportion of active SLE patients seen in the national French care network for lupus in clinical practice. Of note, we observed more ceiling effects, especially in the intimate relationship and planning scales, than in the UK and US studies. Further, international studies should determine whether this difference is related to disease activity or to ethnic, social or cultural features.
Rasch fit statistics was somewhat better with outfit than with infit statistics, with which we encountered mostly overfit problems, which implies that items were less productive for measurement and may produce misleadingly good reliabilities and separations without degrading the measurement system. Less restrictive published rules [37] of 0.51.5 for infit and outfit cutoffs would result in underfit of only four items in both eight-and two-factor structures.
Conclusion
The LupusQoL-FR (supplementary data, available at Rheumatology Online) is reliable and valid for the assessment of SLE patients' heath-related quality of life. Perspectives for future research include testing of the cultural invariance across international studies and confirmation of the accuracy of the two-factor structures.
Rheumatology key messages
. The LupusQoL-FR is valid for use in the eight-or two-scale format. . The LupusQoL-FR shows good measurement properties through Rasch analysis and classical test theory.
